Tag: BCS classification

Bioequivalence Waivers: When the FDA Allows In Vitro Testing Instead of Human Studies
27 Jan, 2026

Bioequivalence Waivers: When the FDA Allows In Vitro Testing Instead of Human Studies

by Trevor Ockley | Jan, 27 2026 | Health | 14 Comments

The FDA allows bioequivalence waivers for certain generic drugs, letting companies skip costly human studies if in vitro dissolution data proves the drug performs the same. Learn which drugs qualify and how the science works.

Continue Reading

Categories

Most popular

Archive